W15QKN21C0014 — REGENERON PHARMACEUTICALS INC — Department of Defense ($5,565,000,000)

PRODUCTION OF THERAPEUTIC IN SUPPORT OF NATIONAL EMERGENCY RESPONSE TO CORONAVIRUS 2019 (COVID-19): IN SUPPORT OF OPERATION WARP SPEED (OWS), THE GOVERNMENT IS PURCHASING UP TO 1,250,000 DOSES OF THE EMERGENCY USE AUTHORIZATION (EUA) THERAPEUTIC. Recipient: REGENERON PHARMACEUTICALS INC Obligated amount: $5,565,000,000 Awarding agency: Department of Defense (Department of the Army) Procurement instrument identifier (PIID): W15QKN21C0014 Start date: 2021-01-12 End date: 2022-07-31

Related documents

• W31P4Q25F0080 — LOCKHEED MARTIN CORPORATION — Department of Defense ($2,990,790,259)#655575
• W31P4Q24C0024 — RAYTHEON COMPANY — Department of Defense ($2,890,141,125)#655576
• W31P4Q23F0006 — LOCKHEED MARTIN CORPORATION — Department of Defense ($1,613,899,475)#655578
• W31P4Q22F0098 — LOCKHEED MARTIN CORPORATION — Department of Defense ($1,026,252,608)#655579
• W58RGZ19C0025 — AMENTUM SERVICES, INC. — Department of Defense ($944,913,878)#655580